For the first time, researchers have shown why precision-tinted lenses reduce headaches for migraine sufferers, a finding that could help improve treatment options for patients battling the debilitating ailment…
Author: Medical News Today
Robotic Navigation Aids For The Visually Impaired
For the visually impaired, navigating city streets or neighborhoods has constant challenges. And most such people still must rely on a very rudimentary technology – a simple cane – to help them make their way through a complex world…
Migraine Relief From Tinted Specs
Precision tinted lenses have been used widely to reduce visual perceptual distortions in poor readers, and are increasingly used for migraine sufferers, but until now the science behind these effects has been unclear…
InSite Vision Receives Special Protocol Assessment From The FDA For The DOUBle Phase 3 Clinical Trial Of AzaSite Plus™ And DexaSite™
InSite Vision Incorporated (OTCBB:INSV) today announced that the Company has reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the design of a Phase 3 clinical trial of AzaSite Plus™ (ISV…
FDA Schedules Advisory Committee Meeting To Discuss BLA For VEGF Trap-Eye For The Treatment Of Wet Age-Related Macular Degeneration
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that the U.S…
Tinted lenses relieve migraine symptoms, neurological proof
Migraine sufferers really do experience relief when they use tinted specs or lenses, and for the first time functional magnetic resonance imaging appears to provide neurological proof, researchers from Michigan State University and the University of Mi…
"I Can Hear A Building Over There" – Researchers Study Blind People’s Ability To Echolocate
Everybody has heard about echolocation in bats and dolphins. These creatures emit bursts of sounds and listen to the echoes that bounce back to detect objects in their environment. What is less well known is that people can echolocate, too…
Risks Associated With Used Football Faceshields
Game-worn football faceshields are more susceptible to breaking when subjected to high-velocity impact than are new faceshields, according to recent research. In the study, researchers used an air cannon to hurl baseballs at new and used polycarbonate …
News From The Journal Of Clinical Investigation: May 23, 2011
NEPHROLOGY: Complex inhibition of severe complication of diabetes Diabetic nephropathy is a serious, sometimes lethal, complication of diabetes (both type 1 and type 2 diabetes). The prevalence of this devastating progressive kidney disease, which of…
A Village Approach To Reducing Falls For Visually Impaired Older Adults
For older adults, a fall can pose a serious health risk. Add in blindness or visual impairment, and the possibility of a fall increases. The approach of “it takes a village” can be applied to reducing the risk of a fall. Cross-disciplinary fall prevent…
New Multidisciplinary Center Takes Innovative Approach To Vision Research
A new vision research center based in Philadelphia will foster regional, national and global collaborations among a diverse group of exceptional clinicians and researchers working to better diagnose, treat and prevent visual diseases…
Visual Abilities May Be Improved By Strobe Eyewear Training
Strobe-like eyewear designed to train the vision of athletes may have positive effects in some cases, according to tests run by a team of Duke University psychologists who specialize in visual perception. The eyewear has lenses that alternate between c…
Improved Form Of Vitamin A May Help In Preventing Blindness From Age-Related Macular Degeneration And Stargardt’s Disease
Slowing down the aggregation or “clumping” of vitamin A in the eye may help prevent vision loss caused by macular degeneration, research from Columbia University Medical Center has found…
Researchers Work On Preventing Blindness From Age-Related Macular Degeneration And Stargardt’s Disease
Slowing down the aggregation or “clumping” of vitamin A in the eye may help prevent vision loss caused by macular degeneration, research from Columbia University Medical Center has found…
Avedro Announces Completion Of 1st US Phase III Corneal Cross-Linking Clinical Trials
Avedro, Inc. today announced the completion of all one-year follow-up visits for patients enrolled in its two multi-center Phase III studies evaluating the safety and efficacy of corneal collagen cross-linking for the treatment of progressive keratocon…
Oraya Therapeutics Completes Enrollment In Pioneering Sham-Controlled Study Of Radiation Therapy For Wet AMD
Oraya Therapeutics, Inc. today announced that it has completed enrollment of its INTREPID clinical trial in Europe. The study is the first sham-controlled, double-masked trial to evaluate the effectiveness and safety of radiation therapy in conjunction…
Seeking A Cure For Premature Baby Blindness
Scientists from the School of Medicine, Dentistry and Biomedical Sciences at Queen’s University Belfast are teaming up to develop a cure to an illness that can lead to blindness in premature babies, thanks to funding from children’s charity Action Medi…
For Innovative Glaucoma Testing, NJIT And UMDNJ License Personal Tonometer Technology
NJIT and UMDNJ have executed a license agreement with The Incubation Factory, St. Louis, MO, covering their personal tonometer technology on which a patent is pending. The tonometer was developed by a research team led by NJIT Professor Gordon Thomas, …
Nanocyrstalline Diamond Aerogel Set To Improve Optics
By combining high pressure with high temperature, Livermore researchers have created a nanocyrstalline diamond aerogel that could improve the optics for something as big as a telescope or as small as the lenses in eyeglasses. Aerogels are a class of ma…
pSivida Announces Resubmission Of New Drug Application For ILUVIEN(R)
pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the in…